|
US4749576A
(en)
*
|
1984-05-10 |
1988-06-07 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
JPS61218517A
(ja)
*
|
1985-03-25 |
1986-09-29 |
Bio Materiaru Yunibaasu:Kk |
経皮吸収製剤
|
|
FR2585246A1
(fr)
*
|
1985-07-26 |
1987-01-30 |
Cortial |
Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
|
|
US4794002A
(en)
*
|
1985-11-01 |
1988-12-27 |
Monsanto Company |
Modified polymeric surfaces and process for preparing same
|
|
JPH0643851B2
(ja)
*
|
1986-03-13 |
1994-06-08 |
大同メタル工業株式会社 |
軸受ユニット
|
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
|
US4780236A
(en)
*
|
1986-06-20 |
1988-10-25 |
Kiwi Brands, Inc. |
Lavoratory cleansing block containing polyethylene gycol disteatrate, guar gum and sodium chloride
|
|
US4743248A
(en)
*
|
1986-08-11 |
1988-05-10 |
Alza Corporation |
Dosage form for delivering acid sensitive beneficial agent
|
|
GB8620845D0
(en)
*
|
1986-08-28 |
1986-10-08 |
Reckitt & Colmann Prod Ltd |
Treatment of textile surfaces
|
|
US5219575A
(en)
*
|
1987-06-26 |
1993-06-15 |
Duphar International Research B.V. |
Compositions with controlled zero-order delivery rate and method of preparing these compositions
|
|
EP0297650A1
(en)
*
|
1987-06-26 |
1989-01-04 |
Duphar International Research B.V |
Compositions with controlled zero-order delivery rate and method of preparing these compositions
|
|
US4910015A
(en)
*
|
1987-10-19 |
1990-03-20 |
Massachusetts Institute Of Technology |
Surface-active polysiloxanes and drug releasing materials thereof
|
|
GB8801863D0
(en)
*
|
1988-01-28 |
1988-02-24 |
Fulmer Yarsley Ltd |
Pharmaceutical formulations with controlled drug release
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
JPH10513471A
(ja)
|
1995-02-10 |
1998-12-22 |
メドトロニック、インコーポレイテッド |
鎮痛薬投与のための方法と装置
|
|
US5945125A
(en)
*
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
|
US6039968A
(en)
*
|
1997-06-24 |
2000-03-21 |
Hoechst Marion Roussel |
Intravaginal drug delivery device
|
|
DE19843904A1
(de)
*
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit polymerem Bindemittel
|
|
DE19843903A1
(de)
*
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit copolymerem Bindemittel
|
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
IL149224A0
(en)
*
|
1999-12-23 |
2002-11-10 |
Pfizer Prod Inc |
Hydrogen-driven drug dosage form
|
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
|
GB0027357D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
|
MXPA03011609A
(es)
|
2001-07-23 |
2004-07-01 |
Alcon Inc |
Dispositivo de entrega de droga oftalmica.
|
|
JP4249611B2
(ja)
*
|
2001-07-23 |
2009-04-02 |
アルコン，インコーポレイティド |
眼薬剤送致装置
|
|
CA2464653C
(en)
*
|
2001-10-29 |
2011-10-18 |
Therics, Inc. |
System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
|
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
|
WO2004098561A2
(en)
|
2003-05-08 |
2004-11-18 |
Nektar Therapeutics Uk Ltd |
Particulate materials
|
|
GB0310636D0
(en)
*
|
2003-05-08 |
2003-06-11 |
Nektar Therapeutics Uk Ltd |
Particulate materials
|
|
BRPI0410542A
(pt)
*
|
2003-07-10 |
2006-06-20 |
Alcon Inc |
dispositivo de administração de medicamento para um olho e método de administrar um agente farmaceuticamente ativo a um olho
|
|
US20060246109A1
(en)
*
|
2005-04-29 |
2006-11-02 |
Hossainy Syed F |
Concentration gradient profiles for control of agent release rates from polymer matrices
|
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
|
EP2664337B1
(en)
|
2005-09-27 |
2019-08-14 |
TissueTech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
|
KR101405545B1
(ko)
|
2005-11-28 |
2014-07-03 |
마리누스 파마슈티컬스 |
ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
|
|
US8246973B2
(en)
|
2006-06-21 |
2012-08-21 |
Advanced Cardiovascular Systems, Inc. |
Freeze-thaw method for modifying stent coating
|
|
CA2657435A1
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
|
PL2529622T3
(pl)
|
2006-09-22 |
2018-07-31 |
Pharmacyclics Llc |
Inhibitory kinazy tyrozynowej brutona
|
|
KR101257550B1
(ko)
|
2007-09-10 |
2013-04-24 |
칼시메디카, 인크 |
세포내 칼슘을 조절하는 화합물
|
|
WO2009073734A2
(en)
|
2007-12-03 |
2009-06-11 |
Medipacs, Inc. |
Fluid metering device
|
|
CN102256969A
(zh)
|
2008-08-27 |
2011-11-23 |
钙医学公司 |
调节胞内钙的化合物
|
|
ES2559029T3
(es)
|
2009-04-24 |
2016-02-10 |
Tissue Tech, Inc. |
Composiciones que contienen al complejo HC.HA y metodos de uso de las mismas
|
|
US9238102B2
(en)
|
2009-09-10 |
2016-01-19 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
|
WO2011130689A1
(en)
|
2010-04-15 |
2011-10-20 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
|
PT2563776T
(pt)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Compostos que modulam o cálcio intracelular
|
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
CA3022256C
(en)
|
2010-06-03 |
2021-03-30 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
|
CN114591311A
(zh)
|
2010-08-27 |
2022-06-07 |
钙医学公司 |
调节细胞内钙的化合物
|
|
US8668675B2
(en)
|
2010-11-03 |
2014-03-11 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
|
CA2767773C
(en)
|
2011-02-11 |
2015-11-24 |
Grain Processing Corporation |
Composition comprising a salt and a crystallization interrupter
|
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
|
CA2837878A1
(en)
|
2011-06-10 |
2012-12-13 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
|
MX365393B
(es)
|
2011-09-13 |
2019-05-31 |
Pharmacyclics Llc |
Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas.
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
SI2800565T1
(sl)
|
2012-01-06 |
2020-10-30 |
Lundbeck La Jolla Research Center, Inc. |
Karbamatne spojine in metode izdelave in uporabe le-teh
|
|
CN104302689A
(zh)
|
2012-03-14 |
2015-01-21 |
麦德医像公司 |
含有过量活性分子的智能聚合物材料
|
|
EA201492082A1
(ru)
|
2012-06-04 |
2015-03-31 |
Фармасайкликс, Инк. |
Кристаллические формы ингибитора тирозинкиназы брутона
|
|
JP2015528001A
(ja)
|
2012-07-11 |
2015-09-24 |
ティッシュテック，インク． |
Ｈｃ−ｈａ／ｐｔｘ３複合体を含む組成物およびその使用方法
|
|
US9416141B2
(en)
|
2012-09-28 |
2016-08-16 |
University Of Washington Through Its Center For Commercialization |
Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
|
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US9382246B2
(en)
|
2013-12-05 |
2016-07-05 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
US10399994B2
(en)
|
2015-02-06 |
2019-09-03 |
University Of Washington |
Compounds and methods for preventing or treating sensory hair cell death
|
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
|
IL315294A
(en)
|
2015-03-03 |
2024-10-01 |
Pharmacyclics Llc |
Pharmaceutical formulations of bruton's tyrosine kinase inhibitor
|
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
|
CN107849021A
(zh)
|
2015-05-11 |
2018-03-27 |
阿比德治疗公司 |
治疗炎症或神经性疼痛的方法
|
|
TWI720984B
(zh)
|
2015-05-20 |
2021-03-11 |
美商帝聖工業公司 |
用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
|
|
EP3344254A1
(en)
|
2015-08-31 |
2018-07-11 |
Pharmacyclics LLC |
Btk inhibitor combinations for treating multiple myeloma
|
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
|
AU2016374497B2
(en)
|
2015-12-16 |
2022-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Inhibition of cytokine-induced SH2 protein in NK cells
|
|
CN108472259A
(zh)
|
2016-01-19 |
2018-08-31 |
詹森药业有限公司 |
包含btk抑制剂的配制品/组合物
|
|
KR20180102150A
(ko)
|
2016-01-19 |
2018-09-14 |
얀센 파마슈티카 엔.브이. |
Btk 저해제를 포함하는 제형/조성물
|
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
DK3442538T3
(da)
|
2016-04-04 |
2025-09-01 |
Sinopia Biosciences Inc |
Behandling af levodopa-induceret dyskinesi med trapidil
|
|
JP2019516773A
(ja)
|
2016-05-25 |
2019-06-20 |
コンセントリック アナルジジックス，インク． |
改善された局所麻酔のための局所麻酔薬及び血管収縮薬と組み合わせたフェノールｔｒｐｖ１アゴニストのプロドラッグ
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
US10549081B2
(en)
|
2016-06-23 |
2020-02-04 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
US11090702B2
(en)
*
|
2016-06-28 |
2021-08-17 |
Trustees Of Tufts College |
Compositions and methods for delivery of active agents
|
|
CA3030821A1
(en)
|
2016-07-18 |
2018-01-25 |
Arthrosi Therapeutics, Inc. |
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
|
|
KR102468670B1
(ko)
|
2016-08-26 |
2022-11-17 |
커타나 파마슈티칼스, 인크. |
Olig2 활성의 억제
|
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
|
EP3541807B1
(en)
|
2016-11-16 |
2021-09-29 |
H. Lundbeck A/S |
A crystalline form of a magl inhibitor
|
|
CN110290791A
(zh)
|
2016-11-16 |
2019-09-27 |
灵北拉荷亚研究中心公司 |
药物制剂
|
|
AU2018325267B2
(en)
|
2017-09-01 |
2023-03-30 |
University Of Washington |
Crystalline forms of compounds for preventing or treating sensory hair cell death
|
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
|
EP3830078A4
(en)
|
2018-07-27 |
2022-03-30 |
Concentric Analgesics, Inc. |
PEGYLATED PRODRUGS OF PHENOLIC TRPV1 AGONISTS
|
|
US12419854B2
(en)
|
2018-12-06 |
2025-09-23 |
Arthrosi Therapeutics, Inc. |
Methods for treating or preventing gout or hyperuricemia
|
|
CN113226302B
(zh)
|
2018-12-06 |
2023-08-18 |
广州瑞安博医药科技有限公司 |
用于治疗或预防痛风或高尿酸血症的化合物的晶型
|
|
SG11202106304RA
(en)
|
2018-12-31 |
2021-07-29 |
Biomea Fusion Llc |
Irreversible inhibitors of menin-mll interaction
|
|
CA3133093A1
(en)
|
2019-03-15 |
2020-09-24 |
Unicycive Therapeutics, Inc. |
Nicorandil derivatives
|
|
US11702393B2
(en)
|
2020-04-21 |
2023-07-18 |
H. Lundbeck A/S |
Synthesis of a monoacylglycerol lipase inhibitor
|
|
US20240124467A1
(en)
|
2020-12-16 |
2024-04-18 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
|
WO2022150525A1
(en)
|
2021-01-06 |
2022-07-14 |
Awakn Life Sciences |
Mdma in the treatment of alcohol use disorder
|
|
CA3218884A1
(en)
|
2021-05-11 |
2022-11-17 |
David Nutt |
Therapeutic aminoindane compounds and compositions
|
|
AU2022283967A1
(en)
|
2021-06-03 |
2024-01-18 |
Arcadia Medicine, Inc. |
Enantiomeric entactogen compositions and methods of their use
|
|
AU2022325861A1
(en)
|
2021-08-11 |
2024-02-29 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
|
CA3229150A1
(en)
|
2021-08-20 |
2023-02-23 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cance
|
|
EP4392028A4
(en)
|
2021-08-23 |
2025-09-24 |
Alexander Shulgin Res Institute Inc |
DEUTERATED EMPATHOGENS
|
|
CA3229910A1
(en)
|
2021-08-23 |
2023-03-02 |
Alexander Shulgin Research Institute, Inc. |
Fluorinated empathogens
|
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
|
IL311211A
(en)
|
2021-09-03 |
2024-05-01 |
Alexander Shulgin Res Institute Inc |
Asymmetric allyl tryptamines
|
|
US20240409558A1
(en)
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
US20250066386A1
(en)
|
2021-11-09 |
2025-02-27 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
|
US11945785B2
(en)
|
2021-12-30 |
2024-04-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of FLT3
|
|
US20250100990A1
(en)
|
2022-01-19 |
2025-03-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
|
US20250179089A1
(en)
|
2022-02-16 |
2025-06-05 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
CN119836422A
(zh)
|
2022-07-06 |
2025-04-15 |
奥比兰制药有限公司 |
S1p受体调节剂的结晶形式
|
|
WO2024155719A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2- pyridinecarboxamide as a covalentinhibitor of menin-mll interaction
|
|
US20250002458A1
(en)
|
2023-05-24 |
2025-01-02 |
Unicycive Therapeutics Inc. |
Salt forms of nicorandil derivative
|
|
WO2024249950A1
(en)
|
2023-06-02 |
2024-12-05 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
US20250145571A1
(en)
|
2023-09-26 |
2025-05-08 |
Unicycive Therapeutics, Inc. |
Amino acid prodrugs of nicorandil
|
|
WO2025194102A1
(en)
|
2024-03-15 |
2025-09-18 |
Unicycive Therapeutics, Inc. |
Pyridine modified nicorandil derivatives
|